You have 9 free searches left this month | for more free features.

rapid virologic response

Showing 51 - 75 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

HCV Reinfection in HD Patients Achieving SVR

Recruiting
  • Hepatitis C Virus Infection
  • +2 more
    • Douliu, Taiwan
    • +6 more
    Feb 22, 2021

    Study of Multidrug-Resistant Patient Outcomes With and Without

    Recruiting
    • HIV Infections
    • Multi-Antiviral Resistance
    • No ibalizumab or Pre-ibalizumab treatment
    • On ibalizumab treatment
    • Los Angeles, California
    • +38 more
    Jan 31, 2023

    Hepatitis B Trial in Worldwide (GSK3228836, PegIFN, NA therapy)

    Active, not recruiting
    • Hepatitis B
    • Sacramento, California
    • +48 more
    Jan 19, 2023

    Diabetic Macular Edema Trial in Puerto Rico, United States (Faricimab)

    Recruiting
    • Diabetic Macular Edema
    • Mesa, Arizona
    • +43 more
    Jan 31, 2023

    CKD Patients Treated With Nirmatrelvir-ritonavir

    Recruiting
    • COVID-19
    • +2 more
    • Shatin, New Territories, Hong Kong
      Prince of Wales Hospital, Chinese University of Hong Kong
    Nov 21, 2022

    Oropharyngeal Cancer Trial in Tampa (Radiotherapy fractionation)

    Active, not recruiting
    • Oropharyngeal Cancer
    • Radiotherapy fractionation
    • Tampa, Florida
      H Lee Moffitt Cancer Center and Research Institute
    Feb 2, 2023

    Severe Mpox in Persons With Advanced HIV

    Recruiting
    • Monkeypox
    • +2 more
      • Atlanta, Georgia
        Centers for Disease Control and Prevention
      Sep 18, 2023

      Contributing Factors for Poor HIV Treatment Response in TB/HIV

      Recruiting
      • Tuberculosis
      • +2 more
      • Observational study
      • Kumasi, Ghana
        Kwame Nkrumah University of Science and Technology
      Mar 23, 2022

      HCV Infection Trial in Phnom Penh (Sofosbuvir/Daclatasvir)

      Not yet recruiting
      • HCV Infection
      • Phnom Penh, Cambodia
        Clinical Trial Unit (Ctu)
      Aug 7, 2023

      Near Patient Molecular Testing in Sepsis

      Active, not recruiting
      • Sepsis
      • Systemic Inflammatory Response Syndrome
        • Los Angeles, California
        • +2 more
        Jul 19, 2022

        HIV Trial in Puerto Rico, Tanzania, United States (Lamivudine, Stavudine, Zidovudine)

        Completed
        • HIV Infections
        • Birmingham, Alabama
        • +39 more
        Oct 27, 2021

        Early Syphilis, Latent, Serological Relapse After Treatment Trial (Benzathine Penicillin G, Doxycycline Capsule)

        Not yet recruiting
        • Early Syphilis, Latent, Serological Relapse After Treatment
        • Benzathine Penicillin G
        • Doxycycline Capsule
        • (no location specified)
        Oct 1, 2023

        Hepatitis C Trial in Baltimore (Patient-Centered Electronic App)

        Recruiting
        • Hepatitis C
        • Patient-Centered Electronic App
        • Baltimore, Maryland
          Johns Hopkins University
        Mar 29, 2022

        HIV Trial (DTG/3TC, Cabotegravir (CAB) LA, Rilpivirine (RPV) LA)

        Not yet recruiting
        • HIV Infections
        • (no location specified)
        Jun 13, 2023

        Sars-CoV2, Covid19 Trial in Toronto (Peginterferon Lambda-1A, Placebo)

        Active, not recruiting
        • Sars-CoV2
        • Covid19
        • Peginterferon Lambda-1A
        • Placebo
        • Toronto, Ontario, Canada
          Toronto General Hospital
        Apr 4, 2022

        type1diabetes, Diabetes, Type 1 Trial in Montreal (Pramlintide, Insulin Lispro, Insulin aspart)

        Not yet recruiting
        • type1diabetes
        • Diabetes Mellitus, Type 1
        • Montreal, Quebec, Canada
          Research Institute of the McGill University Health Center
        Sep 18, 2023

        Hepatitis C, HIV Coinfection Trial in Chennai (Low intensity HCV treatment adherence support, Medium intensity HCV treatment

        Recruiting
        • Hepatitis C
        • HIV Coinfection
        • Low intensity HCV treatment adherence support
        • +2 more
        • Chennai, Tamil Nadu, India
          YR Gaitonde Centre for AIDS Research and Education
        May 12, 2022

        Hepatitis C, Chronic Trial in Taiwan (PEGASYS 180 µg Q1W, P1101 180 µg Q1W, 48 doses, P1101 270µg Q1W, 48 doses)

        Completed
        • Hepatitis C, Chronic
        • PEGASYS 180 µg Q1W
        • +3 more
        • Changhua, Taiwan
        • +12 more
        Oct 7, 2021

        Point of Care Ultrasound to Predict Intensive Care Unit

        Recruiting
        • Sepsis
          • Manhasset, New York
            North Shore University Hospital
          Sep 14, 2022

          Risk Reduction Trial in Cape Town (UTRA, UTRA feedback)

          Recruiting
          • Risk Reduction
          • UTRA
          • UTRA feedback
          • Cape Town, Western Cape, South Africa
            Desmond Tutu Health Foundation, University of Cape Town
          May 17, 2022

          Health Behavior Trial in Eugene (Supported Employment)

          Not yet recruiting
          • Health Behavior
          • Supported Employment
          • Eugene, Oregon
            University of Oregon
          Aug 8, 2023

          Hepatocellular Carcinoma Trial in Villejuif (RAPID procedure)

          Not yet recruiting
          • Hepatocellular Carcinoma
          • RAPID procedure
          • Villejuif, France
            AP-HP, Paul Brousse Hospital
          Jul 24, 2023

          Atrial Fibrillation New Onset, Atrial Fibrillation Paroxysmal Trial in Seoul (Amiodarone, diltiazem or esmolol)

          Terminated
          • Atrial Fibrillation New Onset
          • Atrial Fibrillation Paroxysmal
          • Amiodarone, diltiazem or esmolol
          • Seoul, Korea, Republic of
            Seoul National University Hospital
          Jul 10, 2023

          Hepatitis C, Chronic, Pregnancy; Infection Trial in Pittsburgh (Sofosbuvir/Velpatasvir 400 MG-100 MG Oral Tablet)

          Recruiting
          • Hepatitis C, Chronic
          • Pregnancy; Infection
          • Sofosbuvir/Velpatasvir 400 MG-100 MG Oral Tablet
          • Denver, Colorado
          • +4 more
          Dec 3, 2022

          Human Immunodeficiency Virus-type 1 Infection Trial in Worldwide (Rilpivirine, Efavirenz, Tenofovir disoproxil fumarate)

          Completed
          • Human Immunodeficiency Virus-type 1 Infection
          • Douala, Cameroon
          • +17 more
          Jan 22, 2021